NRJ Group SA
LSE:0IXL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NRJ Group SA
LSE:0IXL
|
FR |
|
D
|
Denka Co Ltd
XBER:DIK
|
JP |
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
|
C
|
Chorus Ltd
ASX:CNU
|
NZ |
|
Acconeer AB
F:2LU
|
SE |
|
U
|
United Overseas Australia Ltd
SGX:EH5
|
MY |
|
P
|
Pennant Group Inc
F:1ZU
|
US |
|
J
|
Johnson Electric Holdings Ltd
XMUN:JOHB
|
HK |
|
A
|
Accredited Solutions Inc
OTC:ASII
|
US |
Wall St Price Targets
0IXL Price Targets Summary
NRJ Group SA
According to Wall Street analysts, the average 1-year price target for 0IXL is 10.08 EUR with a low forecast of 9.68 EUR and a high forecast of 10.59 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0IXL's stock price target?
Price Target
10.08
EUR
According to Wall Street analysts, the average 1-year price target for 0IXL is 10.08 EUR with a low forecast of 9.68 EUR and a high forecast of 10.59 EUR.
What is the Revenue forecast for NRJ Group SA?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is -1%.
What is the Operating Income forecast for NRJ Group SA?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 3 years is 17%.
What is the Net Income forecast for NRJ Group SA?
Projected CAGR
-24%
Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is -24%.
